Insider Stock Trading History of Goldfischer Carl


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Goldfischer Carl since year 2005. The trader's CIK number is 1110780. At the time of this reporting, Goldfischer Carl is the Director of Cymabay Therapeutics, Inc. . (stock ticker symbol CBAY). See this page for all insider trading activities at Cymabay Therapeutics, Inc. .

Note that in the past GOLDFISCHER CARL also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Goldfischer Carl since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-02 CBAY Cymabay Therapeutics, Inc. Option Ex 18,000 2.35 42,210
2017-11-02 CBAY Cymabay Therapeutics, Inc. Sale 18,000 8.66 155,880
2017-05-25 ETRM Enteromedics Inc Sale 4,668 4.85 22,639
2016-01-12 EPZM Epizyme, Inc. Buy 555,555 9.00 4,999,995
2015-09-11 CBAY Cymabay Therapeutics, Inc. Sale 15,467 2.76 42,735
2015-09-10 CBAY Cymabay Therapeutics, Inc. Sale 16,500 2.71 44,715
2015-09-09 CBAY Cymabay Therapeutics, Inc. Sale 14,762 2.76 40,743
2014-09-04 EPZM Epizyme, Inc. Sale 4,000 35.14 140,560
2014-08-26 EPZM Epizyme, Inc. Sale 200,000 35.14 7,027,800
2014-08-25 EPZM Epizyme, Inc. Sale 200,000 35.77 7,153,600
2014-08-22 EPZM Epizyme, Inc. Sale 128,000 32.46 4,154,752
2014-08-21 EPZM Epizyme, Inc. Sale 38,666 33.03 1,277,331
2014-02-10 EPZM Epizyme, Inc. Sale 466,667 29.25 13,650,009
2013-06-05 EPZM Epizyme, Inc. Buy 166,666 15.00 2,499,990
2011-09-23 ETRM Enteromedics Inc Buy 840,000 1.65 1,386,000
2011-06-09 PARD Neorx Corp Option Ex 36,145 .00 0
2010-12-14 ETRM Enteromedics Inc Buy 1,700,000 1.74 2,958,000
2010-03-12 MAPP Map Pharmaceuticals, Inc. Sale 105,000 16.30 1,711,500
2010-03-15 MAPP Map Pharmaceuticals, Inc. Sale 42,176 16.01 675,237
2010-03-16 MAPP Map Pharmaceuticals, Inc. Sale 115,610 16.20 1,872,882
2010-03-09 MAPP Map Pharmaceuticals, Inc. Sale 151,424 15.50 2,347,072
2010-03-10 MAPP Map Pharmaceuticals, Inc. Sale 134,190 16.03 2,151,065
2010-03-11 MAPP Map Pharmaceuticals, Inc. Sale 54,300 16.06 872,057
2009-02-19 ETRM Enteromedics Inc Buy 1,649,485 1.15 1,896,907
2008-10-24 ETRM Enteromedics Inc Buy 49,600 1.10 54,560
2008-04-29 ETRM Enteromedics Inc Buy 25,000 4.50 112,500
2008-04-24 ETRM Enteromedics Inc Buy 50,000 4.50 225,000
2008-02-29 ETRM Enteromedics Inc Buy 20,990 8.66 181,773
2007-11-15 ETRM Enteromedics Inc Buy 375,000 8.00 3,000,000
2007-08-30 PARD Neorx Corp Buy 3,712 5.80 21,514
2007-08-29 PARD Neorx Corp Buy 244 5.75 1,402
2007-08-16 PARD Neorx Corp Buy 227 5.48 1,244
2007-08-14 PARD Neorx Corp Buy 29 5.50 159
2007-08-10 PARD Neorx Corp Buy 675 5.50 3,712
2007-04-30 PARD Neorx Corp Buy 55,227 6.33 349,586
2006-04-26 NERX Neorx Corp Buy 1,244,935 .70 871,454

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldfischer Carl (Director of Cymabay Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.